Effects of lectin-like oxidized LDL receptor-1 (LOX-1) inhibition in human aortic endothelial cells (HAECs). Chih-Sheng Chu Yu-Chen Wang Long-Sheng Lu Brian Walton H. Ramazan Yilmaz Roger Y. Huang Tatsuya Sawamura Richard A. F. Dixon Wen-Ter Lai Chu-Huang Chen Jonathan Lu 10.1371/journal.pone.0070533.g004 https://plos.figshare.com/articles/figure/_Effects_of_lectin_like_oxidized_LDL_receptor_1_LOX_1_inhibition_in_human_aortic_endothelial_cells_HAECs_/767713 <p>(A) HAECs were pretreated with LOX-1 neutralizing antibody TS92 before the introduction of L1 or L5 into cell culture. (B) HAECs were pretreated with TS92 before the introduction of recombinant human CRP (5 or 50 µg/mL) into cell culture. For all experiments, n = 3, and bars shown in graphs represent standard deviation. *<i>P</i><0.05 vs. untreated control.</p> 2013-08-08 02:41:45 Biochemistry proteins lipoproteins Lipoprotein receptors Molecular cell biology chromatography cardiovascular atherosclerosis Diagnostic medicine lectin-like oxidized ldl receptor-1 inhibition aortic endothelial cells